Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06795945 · ClinicalTrials.gov registry record · NA
A Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Safety of a Bovine Thymus Nuclear Extract
A NA study, sponsored by Standard Process.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT06795945 is a NA study that has completed, run by Standard Process. The registered enrollment target is 80 participants.
The verdict
NCT06795945, a NA study, has completed, sponsored by Standard Process.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The goal of this trial is to find out if Thymus Nuclear Extract is safe and well-tolerated in healthy men and women by testing three different dose levels and comparing the results to a placebo.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT TPG1
- DIETARY_SUPPLEMENT TPG2
- DIETARY_SUPPLEMENT TPG3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-02-04 |
| Est. Completion | 2025-11-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06795945
The ClinicalTrials.gov registry entry for NCT06795945 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Standard Process, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT06795945 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06795945 about?
NCT06795945 is a clinical study titled "A Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Safety of a Bovine Thymus Nuclear Extract". The goal of this trial is to find out if Thymus Nuclear Extract is safe and well-tolerated in healthy men and women by testing three different dose levels and comparing the results to a placebo.
What is the current status of trial NCT06795945?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2025-02-04. Estimated completion is 2025-11-24.
What interventions are being tested in trial NCT06795945?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), TPG1 (DIETARY_SUPPLEMENT), TPG2 (DIETARY_SUPPLEMENT), TPG3 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06795945?
This trial is sponsored by Standard Process, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.